1. Home
  2. SLE vs REVB Comparison

SLE vs REVB Comparison

Compare SLE & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLE
  • REVB
  • Stock Information
  • Founded
  • SLE 2014
  • REVB 2020
  • Country
  • SLE United States
  • REVB United States
  • Employees
  • SLE N/A
  • REVB N/A
  • Industry
  • SLE Services-Misc. Amusement & Recreation
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLE Consumer Discretionary
  • REVB Health Care
  • Exchange
  • SLE Nasdaq
  • REVB Nasdaq
  • Market Cap
  • SLE 3.7M
  • REVB 3.8M
  • IPO Year
  • SLE 2019
  • REVB N/A
  • Fundamental
  • Price
  • SLE $3.90
  • REVB $2.42
  • Analyst Decision
  • SLE Strong Buy
  • REVB
  • Analyst Count
  • SLE 2
  • REVB 0
  • Target Price
  • SLE $100.00
  • REVB N/A
  • AVG Volume (30 Days)
  • SLE 76.4K
  • REVB 208.4K
  • Earning Date
  • SLE 08-14-2025
  • REVB 08-08-2025
  • Dividend Yield
  • SLE N/A
  • REVB N/A
  • EPS Growth
  • SLE N/A
  • REVB N/A
  • EPS
  • SLE N/A
  • REVB N/A
  • Revenue
  • SLE $14,691,000.00
  • REVB N/A
  • Revenue This Year
  • SLE N/A
  • REVB N/A
  • Revenue Next Year
  • SLE $30.36
  • REVB N/A
  • P/E Ratio
  • SLE N/A
  • REVB N/A
  • Revenue Growth
  • SLE N/A
  • REVB N/A
  • 52 Week Low
  • SLE $3.63
  • REVB $2.11
  • 52 Week High
  • SLE $53.20
  • REVB $168.00
  • Technical
  • Relative Strength Index (RSI)
  • SLE 37.97
  • REVB 39.19
  • Support Level
  • SLE $3.98
  • REVB $2.26
  • Resistance Level
  • SLE $4.36
  • REVB $2.70
  • Average True Range (ATR)
  • SLE 0.45
  • REVB 0.22
  • MACD
  • SLE -0.05
  • REVB 0.01
  • Stochastic Oscillator
  • SLE 15.65
  • REVB 17.39

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: